PL3875081T3 - Kompozycja farmaceutyczna zawierająca fosforan alkilo karbamoilo naftalenyloksy oktenoilo hydroksyamidu, winan lub ich kombinację, oraz sposób jej wytwarzania - Google Patents
Kompozycja farmaceutyczna zawierająca fosforan alkilo karbamoilo naftalenyloksy oktenoilo hydroksyamidu, winan lub ich kombinację, oraz sposób jej wytwarzaniaInfo
- Publication number
- PL3875081T3 PL3875081T3 PL19878899.4T PL19878899T PL3875081T3 PL 3875081 T3 PL3875081 T3 PL 3875081T3 PL 19878899 T PL19878899 T PL 19878899T PL 3875081 T3 PL3875081 T3 PL 3875081T3
- Authority
- PL
- Poland
- Prior art keywords
- tartrate
- phosphate
- preparation
- combination
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180129576A KR102678356B1 (ko) | 2018-10-29 | 2018-10-29 | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 인산염, 타르타르산염 또는 이들의 조합을 포함하는 약제학적 조성물 및 그 제조방법 |
| PCT/KR2019/014234 WO2020091326A1 (ko) | 2018-10-29 | 2019-10-28 | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 인산염, 타르타르산염 또는 이들의 조합을 포함하는 약제학적 조성물 및 그 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3875081T3 true PL3875081T3 (pl) | 2025-11-24 |
Family
ID=70464189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19878899.4T PL3875081T3 (pl) | 2018-10-29 | 2019-10-28 | Kompozycja farmaceutyczna zawierająca fosforan alkilo karbamoilo naftalenyloksy oktenoilo hydroksyamidu, winan lub ich kombinację, oraz sposób jej wytwarzania |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210346321A1 (pl) |
| EP (1) | EP3875081B1 (pl) |
| JP (1) | JP7613744B2 (pl) |
| KR (1) | KR102678356B1 (pl) |
| CN (1) | CN112930177B (pl) |
| AU (1) | AU2019369913B2 (pl) |
| BR (1) | BR112021006286A2 (pl) |
| CA (1) | CA3116574A1 (pl) |
| ES (1) | ES3036263T3 (pl) |
| MX (1) | MX2021003355A (pl) |
| PL (1) | PL3875081T3 (pl) |
| WO (1) | WO2020091326A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12553903B2 (en) * | 2023-06-01 | 2026-02-17 | Cg Pharmaceuticals, Inc | Ivaltinostat combination therapy for treating pancreatic cancer |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1212723A (fr) * | 1958-01-09 | 1960-03-25 | Rhone Poulenc Sa | Nouveaux dérivés de la phénothiazine à chaîne carbamoylpipérazine et leur préparation |
| US5073376A (en) * | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
| EP1686115A1 (de) * | 2005-01-26 | 2006-08-02 | Novartis AG | Organische Säureadditionssalze von Valnemulin |
| KR100696139B1 (ko) * | 2005-11-01 | 2007-03-20 | 한국화학연구원 | 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시 옥테노일 하이드록시아마이드 유도체 및그의 제조방법 |
| KR100711944B1 (ko) | 2005-11-01 | 2007-05-02 | 한국화학연구원 | 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시프로페닐 하이드록시벤즈아마이드 유도체,이의 제조방법 및 이를 유효성분으로 하는 항암제용 약학조성물 |
| CL2007002499A1 (es) * | 2006-08-30 | 2008-03-14 | Phenomix Corp | Sales citrato y tartrato de compuestos derivados de acido pirrolidinilaminoacetilpirrolidinboronico, inhibidores de dpp-iv; metodo de preparacion; forma solida; combinacion farmaceutica, util para el tratamiento de diabetes. |
| JP5277171B2 (ja) * | 2006-11-03 | 2013-08-28 | コリア リサーチ インスティテュート オブ ケミカル テクノロジーズ | ヒストン脱アセチル化酵素阻害活性を有するナフタレニルオキシプロペニル誘導体およびこれを含む薬学組成物 |
| KR100814092B1 (ko) * | 2006-11-03 | 2008-03-14 | 한국화학연구원 | 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시 옥테노일 하이드록시아마이드 유도체, 이의제조방법 및 이를 유효성분으로 하는 항암제용 약학조성물 |
| KR100814100B1 (ko) * | 2006-11-03 | 2008-03-14 | 한국화학연구원 | 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시프로페닐 하이드록시벤즈아마이드 유도체,이의 제조방법 및 이를 유효성분으로 하는 항암제용 약학조성물 |
| EP2065385A1 (en) * | 2007-11-28 | 2009-06-03 | Laboratorios SALVAT, S.A. | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester |
| KR101388596B1 (ko) | 2008-12-11 | 2014-04-24 | 대한민국 | 잠복성 hiv 감염 세포에서 hiv-1 프로바이러스를 재활성화시키는 히스톤 디아세틸라제 억제제 |
| KR101978364B1 (ko) * | 2017-06-15 | 2019-05-14 | 크리스탈지노믹스(주) | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법 |
-
2018
- 2018-10-29 KR KR1020180129576A patent/KR102678356B1/ko active Active
-
2019
- 2019-10-28 WO PCT/KR2019/014234 patent/WO2020091326A1/ko not_active Ceased
- 2019-10-28 CA CA3116574A patent/CA3116574A1/en active Pending
- 2019-10-28 JP JP2021517997A patent/JP7613744B2/ja active Active
- 2019-10-28 AU AU2019369913A patent/AU2019369913B2/en active Active
- 2019-10-28 ES ES19878899T patent/ES3036263T3/es active Active
- 2019-10-28 BR BR112021006286A patent/BR112021006286A2/pt unknown
- 2019-10-28 EP EP19878899.4A patent/EP3875081B1/en active Active
- 2019-10-28 PL PL19878899.4T patent/PL3875081T3/pl unknown
- 2019-10-28 US US17/283,627 patent/US20210346321A1/en active Pending
- 2019-10-28 CN CN201980071219.1A patent/CN112930177B/zh active Active
- 2019-10-28 MX MX2021003355A patent/MX2021003355A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3875081B1 (en) | 2025-07-09 |
| KR102678356B1 (ko) | 2024-06-26 |
| EP3875081A1 (en) | 2021-09-08 |
| CN112930177B (zh) | 2024-01-30 |
| BR112021006286A2 (pt) | 2021-07-06 |
| ES3036263T3 (en) | 2025-09-16 |
| US20210346321A1 (en) | 2021-11-11 |
| MX2021003355A (es) | 2021-08-11 |
| CN112930177A (zh) | 2021-06-08 |
| AU2019369913B2 (en) | 2024-10-31 |
| CA3116574A1 (en) | 2020-05-07 |
| KR20200047996A (ko) | 2020-05-08 |
| EP3875081A4 (en) | 2022-07-06 |
| AU2019369913A1 (en) | 2021-05-06 |
| WO2020091326A1 (ko) | 2020-05-07 |
| EP3875081C0 (en) | 2025-07-09 |
| JP2022504055A (ja) | 2022-01-13 |
| JP7613744B2 (ja) | 2025-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289763A (en) | Compounds, pharmaceutical compounds and methods for preparing compounds and their use | |
| EP3539963A4 (en) | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE | |
| ZA201906451B (en) | 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same | |
| SG11202111701XA (en) | Coated drug compositions and methods of preparing the same | |
| WO2016149401A3 (en) | Piperazine carbamates and methods of making and using same | |
| IL271807A (en) | New compounds and their pharmaceutical preparations for the treatment of leprosy | |
| PT3580208T (pt) | Derivados de 2-(3-(1h-benzo[d]imidazol-1-il)propil)piperidin-3-ol e compostos relacionados como inibidores de prs para tratamento de, por exemplo, cancro | |
| IL261444A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis | |
| IL276244A (en) | A pharmaceutical preparation for the eyes, a method for its preparation and its application | |
| ZA201901717B (en) | Polymorphic form of kinase inhibitor compound, pharmaceutical composition containing same, and preparation method therefor and use thereof | |
| EP3279207A4 (en) | Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof | |
| EP3176163A4 (en) | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | |
| WO2016077656A3 (en) | Methods and compositions for inhibition of bromodomain and extraterminal proteins | |
| SG11202110674XA (en) | Compound, method and pharmaceutical composition for modulating expression of dux4 | |
| EP3647313A4 (en) | SUBSTITUTED ARYLETHER COMPOUND, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND USE | |
| EP3284743A4 (en) | Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof | |
| EP3636281C0 (en) | METHOD FOR TREATMENT OF DEPRESSION, AND PHARMACEUTICAL COMPOSITION | |
| EP3138834A4 (en) | Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient | |
| IL264511B1 (en) | Aromatic heterocyclic nitrogen compounds, a method for their preparation, their pharmaceutical compositions and their use | |
| HUE047537T2 (hu) | Új heterociklusos vegyület, eljárás annak elõállítására, és az azt tartalmazó gyógyászati készítmény | |
| EP3398608A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER OR CANCER METASTASES WITH PSTL1-PRTEIN AS AN ACTIVE SUBSTANCE | |
| PL3811941T3 (pl) | Kompozycja farmaceutyczna zawierająca ilaprazol i jego sól oraz sposób jej wytwarzania | |
| EP3733670A4 (en) | TETRAHYDROPYRROL COMPOUND, METHOD OF MANUFACTURE THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | |
| HUE065421T2 (hu) | Nazális adagolású rifampicint tartalmazó gyógyszerészeti készítmény demencia kezelésére | |
| PL3898596T3 (pl) | Związek farmaceutyczny, sposób jego wytwarzania i jego zastosowanie jako środek medyczny |